Full-Time

Senior Inventory Control Analyst

Posted on 8/25/2025

Zeiss

Zeiss

1,001-5,000 employees

Supplies lithography optics for semiconductor manufacturing

Compensation Overview

$37 - $46/hr

+ Performance Bonus

Company Does Not Provide H1B Sponsorship

Dublin, CA, USA

In Person

25% travel required for offsite and warehouse visits.

Category
Operations & Logistics (1)
Required Skills
Power BI
SQL
SAP Products
Tableau
Data Analysis
Requirements
  • Minimum of 5 -7-year experience working with Inventory Data Analysis and Supply chain environment.
  • Bachelor’s degree in Business, Accounting, Finance is preferred. Statistics background/education is a plus.
  • Familiar with medical device pricing structure and resale.
  • Knowledge of FDA regulations. Global Logistics knowledge a plus.
  • Strong verbal and written communication skills, including presentation skills.
  • Strong organizational and analytical/problem solving skills.
  • Computer experience (Word, Excel, Power Point, SQL, Access, Power BI, Tableau, SAP).
  • Detail oriented, multi-task, communication skills across entire organization (internal and external).
  • Travel required (25%) offsite and warehouse visits.
Responsibilities
  • Expedite inbound materials; provide targeted receipt dates, and work with the business manager for resolution on any issues.
  • Research and resolve material receipt discrepancies for return inventories.
  • Assist with pricing research and updates to price list.
  • Administer the collection of trade-in materials, both directly and/or through external partners. Schedule logistics -install/shipments to ensure proper pickup and delivery.
  • Liaison to scrap partner vendor for all relevant transactions.
  • Publish and distribute monthly inventory report to sales organizations and sales management including Demo, Trending, Certified and 3PL performance.
  • Maintain and distribute analytical insight, via reporting, for inbound and received inventory, as well as inventory availability, for both ZEISS and third parties, on weekly and monthly basis.
  • Create Dashboards through Power BI and Tableau reports.
  • Track, manage and communicate progress on assigned projects as requested by the Certified Business Management.
  • Monitor inventory levels and aging to identify potential E & O.
  • Create quarterly summary reports and trend analysis to solve complex business issues.
  • Contribute to solving complex business issues through data analysis.
  • Design, publish, and continually identify opportunities and improvements with existing processes and procedures.
  • Ongoing identification of shrink reduction opportunities.
  • Provide top analysis on inventory consumption, variance, and reconciliations.
Desired Qualifications
  • APICS affiliation a plus.
  • Experience in Medical Device industry is a plus.

Zeiss SMT designs and makes high-precision optical systems for semiconductor manufacturing, including lithography optics, photomask solutions, and process-control components. Its products are used in lithography equipment to project circuit patterns onto silicon wafers, with responsibilities spanning advanced optics, mask technology, and monitoring tools that ensure precise, repeatable imaging.

Company Size

1,001-5,000

Company Stage

Growth Equity (Non-Venture Capital)

Total Funding

$1.1B

Headquarters

Oberkochen, Germany

Founded

2001

Simplify Jobs

Simplify's Take

What believers are saying

  • ASML's 24.9% stake secures long-term exclusive optics partnership.
  • Over 8,349 employees across nine global sites drive R&D innovation.
  • SFS's MultiSEM with 91 beams accelerates 2D process optimization.

What critics are saying

  • ASML pressures Zeiss for price cuts, eroding margins in 6-12 months.
  • Intel's 2025 High-NA EUV halt slashes Zeiss revenue by 20%.
  • SMEE's Q1 2026 7nm optics capture 30% of Zeiss Asia revenue.

What makes Zeiss unique

  • Exclusive supplier of optical systems for ASML's EUV lithography machines.
  • Three units: SMO for DUV/EUV/High-NA-EUV optics, SMS for photomasks, SFS for inspection.
  • Advances High-NA-EUV enabling three times more microchip structures.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

Paid Vacation

Performance Bonus

Company News

PR Newswire
Apr 2nd, 2026
ZEISS unveils AI-powered patient platform and enhanced IOL tools at ASCRS

ZEISS has unveiled new digital, AI and surgical innovations for cataract and refractive workflows at the ASCRS conference. The medical technology company is expanding its US cataract portfolio with new irrigation/aspiration handpieces compatible with the DORC EVA NEXUS surgical system, alongside enhanced IOL calculation capabilities for the ZEISS IOLMaster 700. ZEISS also launched VisioGen commercially in the US, a human-verified AI patient engagement platform for ophthalmology practices. The platform integrates with clinic websites to capture patient demand around the clock, with AI-assisted responses reviewed by ZEISS-trained optometrists before delivery. The company showcased ZEISS Collaborative Care, a cloud-based application enabling secure data sharing between eye care professionals, and previewed ZEISS CLINIC 360, pending FDA clearance. ZEISS is celebrating 100 years of US operations this year.

PR Newswire
Mar 24th, 2026
ZEISS expands ophthalmic portfolio in Canada with new diagnostic lasers and workflow tools

ZEISS Medical Technology has expanded its ophthalmic workflow portfolio in Canada with new diagnostic, visualisation and therapeutic solutions. The company will showcase the innovations at upcoming Canadian ophthalmology conferences in Ottawa and Montréal. Key additions include ICGA for ZEISS CLARUS 700, offering simultaneous FA and ICG capture for clinical assessment, and ZEISS VISULAS green with selective laser trabeculoplasty for retinal photocoagulation. The company has introduced refraction devices ZEISS VISUREF 600 and ZEISS VISUCORE 500 to streamline diagnostic workflows. ZEISS also launched VISULAS yag, a new-generation therapeutic laser for anterior segment photodisruption within cataract workflows. The ZEISS FORUM subscription package, now available in Canada, offers integrated data management with unlimited device licences and lower upfront costs.

PR Newswire
Feb 23rd, 2026
ZEISS launches Collaborative Care app for eye care professionals with cloud and on-premises options

ZEISS Medical Technology has launched Collaborative Care, a browser-based application enabling eye care professionals to share data securely, refer patients and coordinate clinical care. Built on the ZEISS Health Data Platform, the solution addresses fragmented data sharing and inefficient referral processes in ophthalmic care. The application offers flexible deployment as either a standalone cloud solution or an integrated extension of ZEISS FORUM. Key features include secure exchange of images and reports, streamlined referral workflows with tracking capabilities, and tools for building professional networks between optometrists and ophthalmologists. ZEISS Collaborative Care was demonstrated at industry events in London and Orlando in February and March 2026. The company generated €2,228 million in revenue in fiscal year 2024/25 with 5,784 employees worldwide.

Handelsblatt
Feb 19th, 2026
Custom Surgical raises $4M to develop AI-powered ophthalmology platform

Custom Surgical, a German ophthalmology company, has raised €3.5 million to advance its platform. The funding will support development of AI-powered features including automated image optimisation and assisted triage processes that help determine case urgency and specialist assignment. The company is already developing its first AI-based triage and screening system. The technology aims to provide initial assessments that guide decisions on how urgently cases need attention and which medical professionals should handle them next.

Investors Hangout
Feb 18th, 2026
Mindpeak raises $15.3M Series A to scale AI cancer diagnostic tools

Mindpeak, an AI-driven pathology startup, raised $15.3 million in a Series A round led by ZEISS Ventures and InnoVentureFund in 2024. The funding will accelerate development and deployment of the company's AI diagnostic tools for cancer pathology. Founded in 2018, Mindpeak's algorithms have supported over 30,000 patient diagnoses across US and European healthcare markets. The technology uses automated histological analyses to help pathologists make faster, more precise clinical decisions. CEO Felix Faber stated the capital would expedite product rollouts and expand capabilities. The company has established strategic partnerships with major players including Roche. Mindpeak operates in the rapidly growing digital pathology market, driven by technological innovation and increasing demand for advanced diagnostic services in an ageing population.

INACTIVE